Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00308100
Recruitment Status : Terminated (Study is prematurely ended due to poor patient recruitment rate.)
First Posted : March 29, 2006
Last Update Posted : January 15, 2009
Information provided by:
Fresenius Kabi

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2008
  Study Completion Date : July 2008